ABO hemolytic disease of the newborn

erythroblastosis fetalis resulting from maternal-fetal incompatibility with respect to an antigen of the ABO blood group; the fetus possesses A or B antigen (or both), that is lacking in the mother, and the mother produces immune antibody, that causes hemolysis of fetal erythrocytes.

Chemwatch helps thousands of organisations manage chemical safety. Book a free demo to see how.
Book a Demo →